OrbiMed’s Forte Biosciences FBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.5M Buy
1,196,955
+603,867
+102% +$7.81M 0.39% 48
2025
Q1
$4.6M Sell
593,088
-6,912
-1% -$53.6K 0.11% 76
2024
Q4
$13.6M Buy
+600,000
New +$13.6M 0.28% 64
2021
Q2
Sell
-6,387
Closed -$5.47M 162
2021
Q1
$5.47M Buy
6,387
+2,699
+73% +$2.31M 0.05% 139
2020
Q4
$3.36M Sell
3,688
-9,931
-73% -$9.04M 0.03% 141
2020
Q3
$16.5M Sell
13,619
-24,394
-64% -$29.6M 0.21% 93
2020
Q2
$13.9M Buy
+38,013
New +$13.9M 0.2% 88